en
Scientific article
Comment
English

Allocating Scarce Unproven Interventions during Public Health Emergencies: Insights from the WHO MEURI Framework

ContributorsMastroleo, Ignacio; Smith, Maxwell; WHO MEURI Working Group
CollaboratorsDagron, Stéphanieorcid
Published inThe American Journal of Bioethics, vol. 20, no. 9, p. 41-44
Publication date2020
Abstract

During the Ebola virus disease outbreak in West Africa, an advisory panel to the World Health Organization (WHO) argued that it can be ethically appropriate to offer individual patients experimental interventions on an emergency basis outside clinical trials provided that certain conditions are met (MEURI framework) In the spirit of finding common ground in the area of using unproven interventions during public health emergencies, we (1) provide a brief introduction to MEURI, (2) compare Webb et al.'s proposal to the existing MEURI framework, and (3) outline key areas where the use and allocation of unproven interventions can be enhanced.

NoteCet article se réfère à Jamie Webb, Lesha D. Shah & Holly Fernandez Lynch (2020) Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization, The American Journal of Bioethics, 20:9, 4-17, DOI: 10.1080/15265161.2020.1795529
Citation (ISO format)
MASTROLEO, Ignacio, SMITH, Maxwell. Allocating Scarce Unproven Interventions during Public Health Emergencies: Insights from the WHO MEURI Framework. In: The American Journal of Bioethics, 2020, vol. 20, n° 9, p. 41–44. doi: 10.1080/15265161.2020.1795539
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1526-5161
331views
2downloads

Technical informations

Creation10/06/2020 4:06:00 PM
First validation10/06/2020 4:06:00 PM
Update time03/15/2023 11:33:02 PM
Status update03/15/2023 11:33:02 PM
Last indexation01/17/2024 11:42:22 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack